Table 2.

Antibiotic susceptibility results for noncarbapenem antibiotics using EUCAST criteria

Antibiotic	No. of isolates inhibited at the following concn (μg/ml)a												MIC (μg/ml)b		% Sc	% Rc
	0.12	0.25	0.5	1	2	4	8	16	32	64	128	256	50%	90%
Ceftazidime				[22	26	22	22	30]	53				8	32	42.2	57.8
Cefepime				[4	16	20	34	49]	52				16	32	52	78
Gentamicin					[23	32	33]	87					8	16	31.4	68.6
Tobramycin					[82	8	4]	81					4	16	51.4	48.6
Amikacin						[72	1	58	22]	22			16	64	41.7	58.3
Netilmicin					[23	0	34]	118					16	16	13.1	86.9
Ciprofloxacin		[39	8	7	6]	115							4	4	26.8	73.2
Levofloxacin	[3	2	5	30	9	9]	117						4	4	22.8	87.2
Fosfomycin									[30	46]	99		128	128	17.1	82.9
Colistin					[169	5]	1						2	2	99.4	0.6
Piperacillin-tazobactam								[85d	17e	28f]	45g		32/4	≥64/4	48.5	51.5

^aLeft and right brackets indicate the lowest and highest concentrations tested, respectively.

^b50% and 90%, MICs at which 50 and 90% of the isolates, respectively, were inhibited.

^cPercentage of susceptible (S) and resistant (R) isolates according to EUCAST criteria.

^dPiperacillin/tazobactam concentrations (μg/ml) were ≤16/4, respectively.

^ePiperacillin/tazobactam concentrations (μg/ml) were 32/4, respectively.

^fPiperacillin/tazobactam concentrations (μg/ml) were 64/4, respectively.

^gPiperacillin/tazobactam concentrations (μg/ml) were >64/4, respectively.